东南亚关税贸易中心
🇲🇾 Malaysia法规

马来西亚传统与草药医学产业税收与合规指南

Traditional & Herbal Medicine Compliance | Malaysia

适用国家🇲🇾 马来西亚 (Malaysia)
资讯类型法规 (Import/Export Regulations)
信息来源MIDA
发布时间

TL;DR

本文系马来西亚投资发展局（MIDA）发布的政策导向性宣介内容，聚焦传统与草药医学产业的创新融合趋势，并隐含对相关企业税务、注册及产品合规的监管要求。关键合规信息包括：1）从事中草药提取物、保健品或OTC传统药品生产/出口的企业须向马来西亚卫生部（MOH）申请产品注册；2）符合MIDA认定的“高价值健康科技项目”可享所得税豁免（Pioneer Status）或投资税赋抵扣（ITC）；3）所有制造企业必须持有由MOH颁发的《药品生产质量管理规范》（cGMP）认证。对企业实际影响在于：未完成MOH产品注册将无法上市销售；错失MIDA激励资格将增加有效税率约20–30%；cGMP认证为强制前置条件，平均耗时4–6个月，需提前规划。

行动清单

  • >立即向马来西亚卫生部（MOH）提交THM产品注册申请，预计处理周期为90–120个工作日
  • >如开展提取物研发或智能制剂生产，6个月内向MIDA提交Pioneer Status或ITA激励资格预审材料
  • >委托经MOH认可的本地实验室完成稳定性与微生物检测，并同步启动cGMP现场审计准备
  • >Submit product registration dossier to Malaysia’s Ministry of Health (MOH) — allow minimum 90 working days for assessment
  • >Apply for MIDA’s Pioneer Status or Investment Tax Allowance (ITA) within 6 months of project commencement if engaged in R&D or advanced manufacturing
  • >Engage an MOH-accredited laboratory for stability and microbiological testing; initiate cGMP gap analysis and documentation preparation

English Summary

This MIDA publication signals regulatory and incentive frameworks for traditional and herbal medicine (THM) enterprises in Malaysia. While not a standalone regulation, it references binding requirements: (1) All THM products for human use must be registered with Malaysia’s Ministry of Health (MOH) under the Control of Drugs and Cosmetics Regulations 1984; (2) Qualifying THM R&D, manufacturing, or export projects may apply for Pioneer Status (tax exemption up to 10 years) or Investment Tax Allowance (ITA) via MIDA; (3) cGMP certification from MOH is mandatory for local manufacturers. Foreign businesses involved in production, import, or distribution must comply—especially those exporting to ASEAN or GCC markets where Malaysian MOH registration serves as mutual recognition basis. Deadlines are project-specific but applications should be submitted at least 6 months prior to commercial launch. Non-compliance risks market access denial and disqualification from fiscal incentives.

需要查询具体 HS 编码的精确税率？

SuperlinkAI 支持单个/批量 HS 编码查询，覆盖 MFN 税率、FTA 优惠税率、落地价计算

SuperlinkAI HS 编码查询 →WhatsApp 咨询

常见问题解答

中国药企在马来西亚销售中成药是否需要重新注册？+
是的。所有进口中成药、草药复方制剂或提取物均须按MOH《药品与化妆品管制条例》单独注册，不可凭中国NMPA批文直接上市。需提供完整质量标准、毒理报告及本地临床使用数据摘要，注册费用约USD 2,500–4,000/品规。
MIDA的税收优惠是否适用于外商独资企业？+
适用。只要投资项目符合MIDA《国家投资政策》中‘健康科技’或‘高附加值制造业’类别，且满足最低资本支出（通常MYR 500万起）和本地雇员比例（≥70%）等条件，外资企业可平等申请Pioneer Status或ITA。
没有马来西亚本地实体能否申请MOH产品注册？+
不能。MOH强制要求注册持有人必须是马来西亚注册公司或持有效营业许可证的本地代理。外资企业须设立本地子公司或委托持证MAH（Marketing Authorization Holder）代为注册并承担法律责任。
cGMP认证是否接受中国GMP证书互认？+
不接受。马来西亚MOH不承认中国NMPA GMP证书。必须通过MOH指定审核机构进行现场检查，重点核查药材溯源系统、重金属/农残检测能力及偏差处理流程，首次认证通过率不足60%，建议预留至少3轮整改周期。
THM企业能否同时享受MIDA激励和MITI中小企业补贴？+
可以叠加，但需分项申报。MIDA激励针对资本性支出与技术升级；MITI的SME Tech Grant则覆盖数字化系统（如ERP、LIMS）采购，最高补贴50%（上限MYR 30万）。二者不可重复申领同一笔支出，需分别准备财务凭证与验收报告。

相关关键词

马来西亚草药医学MIDA税收优惠MOH产品注册cGMP认证马来西亚传统医药合规
官方原文参考点击展开
<p>For centuries, traditional and herbal medicine have supported human health across cultures and civilisations. Today, as the global healthcare landscape evolves, these age-old remedies are gaining renewed relevance — not as alternatives, but as valueble complements to modern medicine.</p> <p>The post <a href="https://www.mida.gov.my/where-nature-meets-innovation-unlocking-the-future-of-traditional-and-herbal-medicine/">Where Nature Meets Innovation: Unlocking the Future of Traditional and Herbal Medicine</a> appeared first on <a href="https://www.mida.gov.my">MIDA | Malaysian Investment Development Authority</a>.</p>
查询具体 HS 编码税率批量查询 + 落地价计算